
Pomerantz LLP Launches Investigation into Anavex Life Sciences
A 34.61% single-day stock plunge followed by the firing of its CEO has prompted Pomerantz LLP to open an investigation into Anavex Life Sciences. The legal firm is now scrutinizing whether the biotechnology company and its leadership engaged in securities fraud or unlawful business practices.
























